Be part of the knowledge.™

Cardiology

643

LikeLikedUnlike

91-105 of 162

Pulmonary Hypertension Management: Practice Trends and Updates
CME/CE Broadcast Replay
Pulmonary Hypertension Management: Practice Trends and Updates
- Vallerie V. McLaughlin, MD
  Peer
- Victor Moles, MD
  Peer
- Ioana Preston, MD
  Peer
1.00 credits
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
CME/CE Broadcast Replay
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
- Vallerie V. McLaughlin, MD
  Peer
- Thomas Cascino, MD
  Peer
- Bradley A. Maron, MD
  Peer
1.00 credits
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
MinuteCE®
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
- Csaba P. Kovesdy, MD
  Peer
- Finnian R. McCausland, MD
  Peer
1.25 program credits
ns-MRAs and eGFR Slope: The Kidney Perspective
MinuteCE®
ns-MRAs and eGFR Slope: The Kidney Perspective
- Csaba P. Kovesdy, MD
  Peer
- Finnian R. McCausland, MD
  Peer
1.25 program credits
FCS and SHTG: Are We Meeting the Need?
CME/CE
FCS and SHTG: Are We Meeting the Need?
- Ira J. Goldberg, MD
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
- Christie Ballantyne, MD
  Peer
0.25 credits
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
- Akshay S. Desai, MD
  Peer
- John McMurray, MD
  Peer
1.25 program credits
advertisement
Mastering MRA Monitoring: The Key to Success
MinuteCE®
Mastering MRA Monitoring: The Key to Success
- Akshay S. Desai, MD
  Peer
- John McMurray, MD
  Peer
1.25 program credits
MinuteCE®
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
- Gianluigi Savarese, MD
  Peer
- James Burton, DM, FRCP
  Peer
- Aaron Wong, MD
  Peer
0.75 credits 3 episodes
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
- Scott Solomon, MD
  Peer
- Mikhail Kosiborod, MD
  Peer
0.50 credits
MinuteCE®
Innovating the clinical management of LDL-c: Exploring CETP as therapeutic target
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
  Peer
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
  Peer
- Erin Michos
  Peer
0.50 credits 3 episodes
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
  Peer
0.50 program credits
CETP inhibition: Lessons from two decades of clinical trials
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
  Peer
0.50 program credits
advertisement
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
MinuteCE®
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
- Erin Michos
  Peer
0.50 program credits
MinuteCE®
Managing hypertrophic cardiomyopathy in clinical practice: The patient journey
- Perry Elliott, MD
  Peer
- Roberto Barriales-Villa, MD, PhD
  Peer
- Iacopo Olivotto, MD
  Peer
0.75 credits 3 episodes
Updates From the 7th World Symposium Task Force
CME/CE
Updates From the 7th World Symposium Task Force
- Eric D. Austin, MD, MSCI
  Peer
- Hilary M. DuBrock, MD
  Peer
- H. James Ford, MD
  Peer
- Gustavo A. Heresi, MD, MS
  Peer
- Gergely Meszaros, JD, MSc
  Peer
- Oksana A. Shlobin, MD
  Peer
- Ioana Preston, MD
  Peer
- Lucilla Piccari, MD, PhD
  Peer
1.00 credits

Program Chapters

Segment Chapters

Playlist:

Recommended